摘要
背景:阿尔茨海默病(AD)是最广泛的年龄相关的神经变性疾病。最近,越来越多的证据表明植物化学用减缓AD的发病和进展。 目的:回顾植物化学对AD治疗的潜在作用。 方法:从现有文献中对用于治疗AD患者的植物化学物质进行系统评价。选择标准包括:1)年龄≥60岁; 2)AD诊断符合国家老年痴呆症协会(NIAAA)的标准,3)适当的措施来评估认知功能和临床状态。 结果:本研究共纳入97篇文章。几种植物化学物质似乎减缓AD发作,延缓疾病进展,并通过抗胆碱能,抗氧化和抗炎功能来针对多种病理原因进行恢复。 结论:植物化学物质及其特定分子靶点的深入了解对于保证安全使用这些化合物作为AD治疗的选择至关重要。
关键词: 植物化学物质,阿尔茨海默病,抗氧化性能,抗炎活性,乙酰胆碱酯酶抑制剂,AChEIs
图形摘要
Current Drug Targets
Title:Phytochemicals in the Treatment of Alzheimer’s Disease: A Systematic Review
Volume: 18 Issue: 13
关键词: 植物化学物质,阿尔茨海默病,抗氧化性能,抗炎活性,乙酰胆碱酯酶抑制剂,AChEIs
摘要: Background: Alzheimer's disease (AD) is the most widespread age-related neurodegenerative disease. Recently, a growing body of evidence suggested the phytochemical use to slow down AD onset and progression.
Objective: To review the phytochemical role potentially involved in AD treatment. Method: A systematic review from existing literature on phytochemicals used in the treatment of AD patients was conducted. Selection criteria included: 1) age≥60 years; 2) AD diagnosis in agreement with the criteria of National Institute on Aging-Alzheimer's Association (NIAAA), and 3) suitable measures to asses cognitive, functional and clinical status. Results: Ninety-seven articles were involved in the present study. Several phytochemicals seem to slow down AD onset, delay disease progression and let recovery through targeting multiple pathological causes by anti-cholinergic, antioxidant and anti-inflammatory features. Conclusion: Deeper knowledge on phytochemicals and their specific molecular targets is essential to guarantee safe use of these compounds as an option for AD treatment.Export Options
About this article
Cite this article as:
Phytochemicals in the Treatment of Alzheimer’s Disease: A Systematic Review, Current Drug Targets 2017; 18 (13) . https://dx.doi.org/10.2174/1389450117666161102121553
DOI https://dx.doi.org/10.2174/1389450117666161102121553 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Expression and Function of Cytokines and Chemokines in Neuropsychiatric Related Systemic Lupus Erythematosus
Current Rheumatology Reviews A Stress Repair Mechanism That Maintains Vertebrate Structure During Stress
Cardiovascular & Hematological Disorders-Drug Targets Nitroso-Redox Balance and Modulation of Basal Myocardial Function: An Update from the Italian Society of Cardiovascular Research (SIRC)
Current Drug Targets Novel Aspects in the Pathophysiology of Peripheral Vasculopathy in Systemic Sclerosis
Current Rheumatology Reviews Anti-Endothelial Cell Antibodies in Patients with Cerebral Small Vessel Disease
Current Neurovascular Research Predicting Toxicity: Biomarkers and the Value of the Patient's Opinion
Current Pharmaceutical Design The Role of Nuclear Receptor PPARα in the Sleep-wake Cycle Modulation. A Tentative Approach for Treatment of Sleep Disorders
Current Drug Delivery Therapeutic AIDS Vaccines
Current Pharmaceutical Design Radix Paeoniae Rubra Ameliorates Lupus Nephritis in Lupus-Like Symptoms of Mrl Mice by Reducing Intercellular Cell Adhesion Molecule-1, Vascular Cell Adhesion Molecule-1, and Platelet Endothelial Cell Adhesion Molecule-1 Expression
Combinatorial Chemistry & High Throughput Screening Pharmacological Interventions on Asymmetric Dimethylarginine, a Clinical Marker of Vascular Disease
Current Medicinal Chemistry Evidence for Altered LRP/RAGE Expression in Alzheimer Lesion Pathogenesis
Current Alzheimer Research Rituximab Therapy and Autoimmune Disease
Current Immunology Reviews (Discontinued) Haemostatic Activation in HIV Infected Patients Treated with Different Antiretroviral Regimens
Current HIV Research Biologic Therapy in Inflammatory Eye Conditions (Ophtalmology): Safety Profile
Current Drug Safety Non-Analgesic Effects of Opioids: Neuroprotection in the Retina
Current Pharmaceutical Design Skin Tests in the Diagnosis of Drug Hypersensitivity Reactions
Current Pharmaceutical Design Adverse Reactions Induced by Minocycline: A Review of Literature
Current Drug Safety Anti-Inflammatory and Anti-Allergy Drugs in Rhinosinusitis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Levamisole-Induced Leukoencephalopathy in Russia: Analysis of 30 Cases
Current Drug Safety A Review of the Treatment of Psoriasis with Infliximab
Reviews on Recent Clinical Trials